AzTrials
AzTrials

Rotator Cuff TendinosisNCT05483517

High Energy Density Pulse Electromagnetic Field for Patients With Rotator Cuff Tendinopathy

A study testing High energy density pulse electromagnetic field and physiotherapy in people with Rotator Cuff Tendinosis, run by Tri-Service General Hospital (TSGH) at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with rotator cuff tendinopathy Read more about this study

Who is it for?
Ages 20 to 75 years
Conditions the study is for
Rotator Cuff Tendinosis
What is being tested?
High energy density pulse electromagnetic field and physiotherapy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteTaiwan
Study dates
31 Jan 2023to 30 Aug 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age between 20 to 75 years old
  • persistent shoulder pain for at least 3 months and pain VAS score >=5
  • positive result in any of the following physical examinations: Hawkins-Kennedy, Neer or Jobe tests
  • confirmed rotator cuff tendinopathy by ultrasonography or MRI

Who cannot join

  • complete or full-thickness tear of rotator cuff found by ultrasonography or MRI
  • previous shoulder surgery
  • previous history of severe trauma in shoulder
  • cervical radiculopathy related shoulder pain or referred pain
  • other shoulder diseases: adhesive capsulitis, calcifying tendinopathy, radiology-confirmed acromion type III, shoulder instability, degenerative osteoarthritis, labral tear
  • present with any of the following systemic diseases: active infection, sever and uncontrolled medical condition, cancer, immune-related or rheumatoid arthritis, hyperuricemia and gout
Show all 10Show fewer
  • previous treatment with articular or subacromial steroid injections within the last 3 months
  • cognitive impairment with loss of ability to sign the agreement and receive rehabilitation
  • pregnancy or lactating women
  • has any of the following contraindications: Carriers of pacemakers, internal defibrillators,internal metal implants (locally dependent), Cochlea implants, metallic stents, insulin pumps

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Tri-service general hospital

    Taipei, Neihu, 11490

Other trials in Taiwan

About this study

Official title: Efficacy of High Energy Density Pulse Electromagnetic Field for Patients With Rotator Cuff Tendinopathy: A Double-blinded, Randomized Controlled Trail

The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with rotator cuff tendinopathy

Read the detailed description

Traditional pulse electromagnetic field (PEMF) devices have been approved by the U.S. Food and Drug Administration (FDA) to treat nonunion fractures and cleared to treat post-operative pain and edema, osteoarthritis, and plantar fasciitis. However, high level of evidence indicated that the lack of beneficial effects of PEMF on pain, function or range of motion in the treatment of shoulder pain.

High energy density pulse electromagnetic field(High-PEMF) which builds up a voltage up to 30 kilovolt (kV) with shorter impulse time(50us) and broad band-width(200kHz~300MHz) is very different from traditional PEMF. Magnetic field about 50~150 millitesla (mT) is created and it can penetrate the body up to 20 cm. The aim of our study is to investigate the efficacy of High-PEMF for patients with rotator cuff tendinopathy.

Being tested
High energy density pulse electromagnetic field, sham High energy density pulse electromagnetic field, physiotherapy
Keywords
rotator cuff tendinopathy, high energy density pulse electromagnetic field
Medical subject headings
Rotator Cuff Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High energy density pulse electromagnetic fieldDevice

    The treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. A normal energy of high-PEMF with a rate of 2 pulse per second is applied to the patient.

  • sham High energy density pulse electromagnetic fieldDevice

    The sham treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. The setting is the same as the experimental group(normal energy, a rate of 2 pulse per second) with the difference that the energy output doesn't export to the patient.

  • physiotherapyBehavioural

    Physiotherapy includes shoulder range of motion (ROM), stretching and muscle strengthening exercises. Under the physiotherapist's guidance, the patient receives the training session about 30 minutes every time.

Study groups in NCT05483517
Study groupRoleWhat they receive
physiotherapy and high-PEMFExperimentalThe patient receives physiotherapy under the physiotherapist's guidance and high-PEMF therapy for three weeks, following two sessions a week.
Receives: Device: High energy density pulse electromagnetic field; Behavioral: physiotherapy
physiotherapy and sham high-PEMFSham comparatorThe patient receives physiotherapy under the physiotherapist's guidance and sham high-PEMF therapy for three weeks, following two sessions a week.
Receives: Device: sham High energy density pulse electromagnetic field; Behavioral: physiotherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Pain Visual Analogue Scale(VAS)

    The Visual Analog Scale (VAS) was used to measure pain intensity. The scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the worst possible pain. Higher scores indicate worse outcomes.

    Measured: baseline, immediate after treatment, 4 weeks, 12 weeks

Secondary outcomes (4)
  1. Change in Total Score of Shoulder Pain and Disability Index (SPADI)

    The Shoulder Pain and Disability Index (SPADI) is a patient completed questionnaire with 13 items assessing pain level and extent of difficulty with activity of daily livings (ADLs) requiring the use of the upper extremities. The pain subscale has 5-items and the Disability subscale has 8-items. The patient is instructed to choose the number that best describes their level of pain and extent of difficulty using the involved shoulder. The pain scale is summed up to a total of 50 while the disability scale sums up to 80.

    The total SPADI score is calculated by adding the scores of the Pain and Disability subscales, with a range from 0 to 130. A higher total score indicates greater pain and disability.

    Measured: baseline, immediate after treatment, 4 weeks, 12 weeks

  2. Changes of Shoulder Range of Motion in Active Flexion

    Shoulder ROM during flexion, abduction in the sitting position, internal rotation (IR) at 90° of abduction of the affected shoulder were measured using a digital goniometer, and the mean of three values was used for analysis

    Measured: baseline, immediate after treatment, 4 weeks, 12 weeks

  3. Changes of Shoulder Range of Motion in Active Abduction

    Shoulder ROM during flexion, abduction in the sitting position, internal rotation (IR) at 90° of abduction of the affected shoulder were measured using a digital goniometer, and the mean of three values was used for analysis

    Measured: baseline, immediately after treatment, 4 weeks, 12 weeks

  4. Changes of Shoulder Range of Motion in Active Internal Rotation

    Shoulder ROM during flexion, abduction in the sitting position, internal rotation (IR) at 90° of abduction of the affected shoulder were measured using a digital goniometer, and the mean of three values was used for analysis

    Measured: baseline, immediately after treatment, 4 weeks, 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2022
  2. Study start31 Jan 2023
  3. Primary completion8 Apr 2024
  4. Study completion30 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05483517
Sponsor's protocol ID
A202205076
Status last verified
Feb 2025
First submitted
29 Jul 2022
Last updated
25 Feb 2025
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing High energy density pulse electromagnetic field and physiotherapy in people with Rotator Cuff Tendinosis, run by Tri-Service General Hospital (TSGH) at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 25 Feb 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Pain Visual Analogue Scale(VAS) (time frame: baseline, immediate after treatment, 4 weeks, 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in